| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 6-K | Report | FORM 6-K | Sep 19, 2024 | Sep 19, 2024 |
| 6-K | Report | FORM 6-K | Aug 27, 2024 | Aug 27, 2024 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) | Aug 14, 2024 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) | Aug 5, 2024 | |
| 6-K | Report | FORM 6-K | Jul 22, 2024 | Jul 22, 2024 |
| 6-K | Report | FORM 6-K | Jul 15, 2024 | Jul 15, 2024 |
| 6-K | Report | FORM 6-K | Jul 1, 2024 | Jul 1, 2024 |
| 6-K | Report | FORM 6-K | Jun 6, 2024 | Jun 6, 2024 |
| 6-K | Report | FORM 6-K | Jun 5, 2024 | Jun 5, 2024 |
| 6-K | Report | FORM 6-K | Apr 29, 2024 | Apr 29, 2024 |
| 20-F | Report | Data | FORM 20-F | Apr 18, 2024 | Dec 31, 2023 |
| 6-K | Report | FORM 6-K | Apr 18, 2024 | Apr 18, 2024 |
| 6-K | Report | FORM 6-K | Apr 3, 2024 | Apr 3, 2024 |
| 6-K | Report | FORM 6-K | Jan 30, 2024 | Jan 30, 2024 |
| 6-K/A | Report | Data | EXHIBIT-99.1 | Dec 21, 2023 | Jun 30, 2023 |
| 6-K | Report | FORM 6-K | Dec 20, 2023 | Dec 20, 2023 |
| 6-K | Report | FORM 6-K | Dec 14, 2023 | Dec 14, 2023 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) | Dec 8, 2023 | |
| SC 13D/A | Report | SC 13D/A | Nov 29, 2023 | |
| 6-K | Report | FORM 6-K | Nov 29, 2023 | Nov 29, 2023 |
| 6-K | Report | FORM 6-K | Nov 28, 2023 | Nov 28, 2023 |
| 6-K | Report | FORM 6-K | Nov 14, 2023 | Nov 14, 2023 |
| 6-K | Report | FORM 6-K | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Report | FORM 6-K | Oct 20, 2023 | Oct 20, 2023 |
| 6-K | Report | FORM 6-K | Oct 6, 2023 | Oct 6, 2023 |
| 6-K | Report | FORM 6-K | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Report | FORM 6-K | Sep 5, 2023 | Sep 5, 2023 |
| 6-K | Report | FORM 6-K | Sep 5, 2023 | Sep 4, 2023 |
| 6-K | Report | FORM 6-K | Aug 10, 2023 | Aug 10, 2023 |
| 6-K | Report | FORM 6-K | Aug 3, 2023 | Aug 3, 2023 |
| 6-K | Report | FORM 6-K | Jul 24, 2023 | Jul 24, 2023 |
| 6-K | Report | FORM 6-K | Jun 15, 2023 | Jun 15, 2023 |
| 6-K | Report | FORM 6-K | Jun 1, 2023 | Jun 1, 2023 |
| 6-K | Report | FORM 6-K | May 18, 2023 | May 18, 2023 |
| 6-K | Report | FORM 6-K | May 11, 2023 | May 11, 2023 |
| 6-K | Report | FORM 6-K | May 10, 2023 | May 10, 2023 |
| 6-K | Report | FORM 6-K | May 5, 2023 | May 5, 2023 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) | Apr 10, 2023 | |
| SC 13D/A | Report | SC 13D/A | Apr 5, 2023 | |
| 6-K | Report | FORM 6-K | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Report | FORM 6-K | Apr 4, 2023 | Apr 4, 2023 |
| 6-K | Report | FORM 6-K | Apr 3, 2023 | Apr 3, 2023 |
| SC 13D/A | Report | SC 13D/A | Mar 31, 2023 | |
| 6-K | Report | FORM 6-K | Mar 30, 2023 | Mar 30, 2023 |
| 20-F | Report | Data | FORM 20-F | Mar 30, 2023 | Dec 31, 2022 |
| SC 13G/A | Report | Feb 16, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | Feb 14, 2023 | ||
| 6-K | Report | FORM 6-K | Feb 9, 2023 | Feb 9, 2023 |
| SC 13G/A | Report | Feb 8, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 6, 2023 | |
| 6-K | Report | FORM 6-K | Feb 6, 2023 | Feb 6, 2023 |
| 6-K | Report | FORM 6-K | Jan 19, 2023 | Jan 19, 2023 |
| 6-K | Report | FORM 6-K | Dec 8, 2022 | Dec 8, 2022 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 | Nov 28, 2022 | |
| SC 13D/A | Report | SC 13D/A | Nov 23, 2022 | |
| 6-K | Report | FORM 6-K | Nov 14, 2022 | Nov 14, 2022 |
| SC 13D/A | Report | SC 13D/A | Nov 9, 2022 | |
| 6-K | Report | FORM 6-K | Nov 3, 2022 | Nov 3, 2022 |
| 6-K | Report | FORM 6-K | Nov 1, 2022 | Nov 1, 2022 |
| 6-K/A | Report | Data | EXHIBIT 99.1 | Sep 14, 2022 | Jun 30, 2022 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 | Aug 23, 2022 | |
| 6-K | Report | FORM 6-K | Aug 18, 2022 | Aug 18, 2022 |
| 6-K | Report | FORM 6-K | Aug 15, 2022 | Aug 15, 2022 |
| SC 13D/A | Report | SC 13D/A | Aug 5, 2022 | |
| 6-K | Report | FORM 6-K | Jul 26, 2022 | Jul 26, 2022 |
| 6-K | Report | FORM 6-K | Jul 22, 2022 | Jul 22, 2022 |
| 6-K | Report | FORM 6-K | Jul 21, 2022 | Jul 21, 2022 |
| 6-K | Report | FORM 6-K | Jul 21, 2022 | Jul 21, 2022 |
| 6-K | Report | FORM 6-K | Jun 17, 2022 | Jun 17, 2022 |
| 6-K | Report | FORM 6-K | May 27, 2022 | May 27, 2022 |
| 6-K | Report | FORM 6-K | May 10, 2022 | May 10, 2022 |
| 6-K | Report | FORM 6-K | May 5, 2022 | May 5, 2022 |
| 6-K | Report | FORM 6-K | Apr 13, 2022 | Apr 13, 2022 |
| 6-K | Report | FORM 6-K | Apr 6, 2022 | Apr 6, 2022 |
| 6-K | Report | FORM 6-K | Mar 31, 2022 | Mar 31, 2022 |
| 6-K | Report | FORM 6-K | Mar 10, 2022 | Mar 10, 2022 |
| 20-F | Report | Data | 20-F | Mar 10, 2022 | Dec 31, 2021 |
| SC 13G/A | Report | SC 13G/A - AMENDMENT NO. 2 | Feb 18, 2022 | |
| SC 13G | Report | SC 13G | Feb 15, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G | Report | ADDEX THERAPEUTICS | Feb 14, 2022 | |
| SC 13G/A | Report | NONE | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2022 | |
| 6-K | Report | FORM 6-K | Feb 3, 2022 | Feb 3, 2022 |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 | Jan 10, 2022 | |
| 6-K | Report | FORM 6-K | Dec 20, 2021 | Dec 17, 2021 |
| 6-K | Report | FORM 6-K | Dec 15, 2021 | Dec 15, 2021 |
| 6-K | Report | FORM 6-K | Nov 15, 2021 | Nov 15, 2021 |
| 6-K | Report | FORM 6-K | Nov 4, 2021 | Nov 4, 2021 |
| 6-K | Report | FORM 6-K | Sep 29, 2021 | Sep 29, 2021 |
| 6-K | Report | FORM 6-K | Sep 22, 2021 | Sep 22, 2021 |
| SC 13D/A | Report | SC 13D/A | Sep 8, 2021 | |
| 6-K | Report | FORM 6-K | Aug 5, 2021 | Aug 5, 2021 |
| 6-K | Report | FORM 6-K | Aug 2, 2021 | Aug 2, 2021 |
| 6-K | Report | FORM 6-K | Jul 29, 2021 | Jul 29, 2021 |
| 6-K | Report | FORM 6-K | Jul 1, 2021 | Jul 1, 2021 |
| 6-K | Report | FORM 6-K | Jun 30, 2021 | Jun 29, 2021 |
| 6-K | Report | FORM 6-K | Jun 29, 2021 | Jun 29, 2021 |
| 6-K | Report | FORM 6-K | Jun 17, 2021 | Jun 17, 2021 |
| 6-K | Report | FORM 6-K | Jun 7, 2021 | Jun 7, 2021 |
| 6-K | Report | FORM 6-K | May 17, 2021 | May 17, 2021 |
| 6-K | Report | FORM 6-K | May 14, 2021 | May 14, 2021 |
| 6-K | Report | FORM 6-K | May 5, 2021 | May 5, 2021 |
| 6-K | Report | FORM 6-K | Apr 26, 2021 | Apr 26, 2021 |
| 6-K | Report | FORM 6-K | Apr 8, 2021 | Apr 8, 2021 |
| 6-K | Report | FORM 6-K | Mar 11, 2021 | Mar 11, 2021 |
| 20-F | Report | Data | 20-F | Mar 11, 2021 | Dec 31, 2020 |
| 6-K | Report | FORM 6-K | Feb 17, 2021 | Feb 17, 2021 |
| SC 13G | Report | Feb 16, 2021 | ||
| 6-K | Report | FORM 6-K | Feb 16, 2021 | Feb 16, 2021 |
| SC 13G | Report | NONE | Feb 12, 2021 | |
| SC 13G | Report | SC 13G | Feb 10, 2021 | |
| SC 13D | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D | Jan 22, 2021 | |
| 6-K | Report | FORM 6-K | Jan 21, 2021 | Jan 21, 2021 |
| 6-K | Report | FORM 6-K | Jan 12, 2021 | Jan 11, 2021 |
| 6-K | Report | FORM 6-K | Jan 7, 2021 | Jan 7, 2021 |
| 6-K | Report | FORM 6-K | Dec 14, 2020 | Dec 14, 2020 |
| SC 13D | Report | SC 13D | Nov 3, 2020 | |
| 6-K | Report | FORM 6-K | Nov 3, 2020 | Nov 3, 2020 |
| 6-K | Report | FORM 6-K | Nov 2, 2020 | Nov 2, 2020 |
| 6-K | Report | FORM 6-K | Aug 27, 2020 | Aug 27, 2020 |
| 6-K | Report | 6-K | Aug 12, 2020 | Aug 12, 2020 |
| 6-K | Report | FORM 6-K | Jul 20, 2020 | Jul 20, 2020 |
| 6-K | Report | FORM 6-K | Jun 16, 2020 | Jun 16, 2020 |
| 6-K | Report | FORM 6-K | Jun 10, 2020 | Jun 10, 2020 |
| 6-K | Report | 6-K | May 20, 2020 | May 20, 2020 |
| 6-K | Report | FORM 6-K | May 19, 2020 | May 19, 2020 |
| 20-F | Report | Data | 20-F | Apr 27, 2020 | Dec 31, 2019 |
| 6-K | Report | FORM 6-K | Apr 8, 2020 | Apr 8, 2020 |
| 6-K | Report | 6-K | Mar 18, 2020 | Mar 18, 2020 |
| 6-K | Report | 6-K | Mar 6, 2020 | Mar 3, 2020 |